Amiodarone is one of the commonly used anti-arrhythmic agents with well-recognized chronic pulmonary toxicity. We present our experience of a patient with a fatal outcome after coronary artery bypass grafting and a short course of amiodarone treatment with a low total cumulative dose for the treatment of postoperative atrial fibrillation. Necropsy revealed diffuse pulmonary damage due to acute amiodarone lung toxicity.
Get full access to this article
View all access options for this article.
References
1.
RotmenschHHLironMTupilskyMLaniadoS. Possible association of pneumonitis with amiodarone therapy. Am Heart J1980; 100: 412–3.
2.
KaushikSHussainAClarkePLazarHL. Acute pulmonary toxicity after low-dose amiodarone therapy. Ann Thorac Surg2001; 72: 1760–1.
DaoudEGStrickbergerSAManKCGoyalRDeebGMBollingSFPaganiFDBitarCMeissnerMDMoradyF. Preoperative amiodarone as prophylaxis against atrial fibrillation after heart surgery. N Engl J Med.1997 Dec 18; 337 (25): 1785–91.
5.
GuarnieriTNolanSGottliebSODudekALowryDR. Intravenous amiodarone for the prevention of atrial fibrillation after open heart surgery: the Amiodarone Reduction in Coronary Heart (ARCH) trial. J Am Coll Cardiol1999; 34: 343–7.
6.
AshrafianHDaveyP. Is amiodarone an underrecognized cause of acute respiratory failure in the ICU?Chest2001; 120: 275–82.
7.
DeanPJGroshartKDPorterfieldJGIansmithDHGoldenEBJrAmiodarone-associated pulmonary toxicity. A clinical and pathologic study of eleven cases. Am J Clin Pathol1987; 87: 7–13.
8.
LardinoisDHandschinAWederW. Acute amiodarone-induced pulmonary toxicity after lung operation. Ann Thorac Surg2002; 73: 2033–4.
